Antiarrhythmic versus antiarrhythmic: study Excluded of the Systematic review
DISEASE INTERVENTION COMPARISON RESULTS
J Clin Pharmacol. 1995 May;35(5):471-7 Randomized Controlled Trial
IN StudyID: Babuty 1999 (subordinated publication), atrial fibrillation, paroxysmal The Use of
cibenzoline
As Treatment, Chronic
Is equal Than
flecainide
To AF recurrence, adverse effects, pro-arrhythmia - at 6 months
Ann Cardiol Angeiol (Paris). 1997 Feb;46(2):109-16 Randomized Controlled Trial, Multicenter Trial
IN StudyID: Babuty 1999 (subordinated publication), atrial fibrillation, paroxysmal The Use of
cibenzoline
As Treatment, Chronic
Is equal Than
flecainide
To AF recurrence, adverse effects, pro-arrhythmia - at 6 months
Annals of Noninvasive Electrocardiology. 1999;4(1):53-59 Randomized Controlled Trial
IN StudyID: Babuty 1999, atrial fibrillation, paroxysmal The Use of
cibenzoline
As Treatment, Chronic
Is equal Than
flecainide
To AF recurrence, adverse effects, pro-arrhythmia - at 6 months
Deutsche Medizinische Wochenschrift. 1978 Jun 30;103(26):1068-72 Randomized Controlled Trial
IN StudyID: Beck 1978, atrial fibrillation, persistent The Use of
propafenone
As Treatment, Acute
Is equal Than
lidoflazine
To acute conversion of AF
Arch Mal Coeur Vaiss. 1985 Oct; 78 Spec No: 99-103 Randomized Controlled Trial
IN StudyID: Frances 1985, atrial fibrillation The Use of
cibenzoline
As Treatment, Chronic
Is equal Than
quinidine
To AF recurrences, adverse effects - at 6 months
Br Heart J. 1977;39(5):540-6 Clinical Trial (non-controlled, non-randomized)
IN StudyID: Kenelly 1977, atrial fibrillation, persistent The Use of
lidoflazine
As Treatment, Chronic
Is worse Than
quinidine
To mortality: The trial was stopped after 4 patients died while receiving lidoflazine, probably by drug-induced arrhythmias
Ann Cardiol Angeiol (Paris). 1996 Oct;45(8):469-79 Randomized Controlled Trial, Multicenter Trial
IN StudyID: Lardoux 1996, atrial fibrillation The Use of
cibenzoline
As Treatment, Chronic
Is equal Than
propafenone
To AF recurrence, adverse effects, pro-arrhythmia - at 6 months
Am Heart J. 1992 Sep;124(3):645-50 Cross-Over
IN StudyID: Lau 1992, atrial fibrillation, paroxysmal, recurrent The Use of
flecainide
As Treatment, Chronic
Is equal Than
quinidine
To AF recurrence, adverse effects - at 2 months
British Journal of Clinical Practice. Supplement. 1986 Apr;44:52-60 Controlled Trial (non-randomized)
IN StudyID: Martin 1986, atrial fibrillation, paroxysmal The Use of
amiodarone
As Treatment, Chronic
Is not available Than
disopyramide
To not available
New Trends in Arrhytmias. 1991;7(4):693-698 Cross-Over
IN StudyID: Massacci 1991, atrial fibrillation, paroxysmal, recurrent The Use of
amiodarone
As Treatment, Chronic
Is equal Than
flecainide
To AF recurrence, adverse effects - at 4 weeks
Ter Arkh. 1990; 62(9): 47-51 not available
IN StudyID: Nedostup 1990, atrial fibrillation The Use of
amiodarone
As Treatment, Chronic
Is - Than
quinidine
To not available
Arch Mal Coeur Vaiss. 1998 Dec;91(12):1481-6 Randomized Controlled Trial, Multicenter Trial
IN StudyID: Piot 1998, atrial fibrillation The Use of
cibenzoline
As Treatment, Chronic
Is equal Than
disopyramide
To AF recurrence, adverse effects - at 6 months
Br J Clin Pract Suppl. 1986 Apr;44:42-8 Cross-Over
IN StudyID: Tonet 1986, atrial fibrillation The Use of
amiodarone
As Treatment, Chronic
Is unknown Than
quinidine
To unknown
Ann Cardiol Angeiol (Paris). 1995 Nov;44(9):525-31 Randomized Controlled Trial
IN StudyID: Touboul 1996, atrial fibrillation The Use of
cibenzoline
As Treatment, Chronic
Is equal Than
quinidine
To AF recurrence, adverse effects, pro-arrhythmia - at 6 months
J Cardiovasc Pharmacol. 1989 Jan;13(1):32-6 Cross-Over
IN StudyID: Van Wijk 1989, atrial fibrillation, paroxysmal, recurrent The Use of
flecainide
As Treatment, Chronic
Is better Than
quinidine
To AF recurrence, adverse effects - at 3 months
Eur Heart J. 2003 Aug;24(15):1425-9 Randomized Controlled Trial, Multicenter Trial
IN StudyID: VERARAF 2003, atrial fibrillation, persistent The Use of
amiodarone, flecainide, verapamil
As Treatment, Chronic
Is equal Than
flecainide, verapamil addition to any of both
To AF recurrence - at 3? Month
Z Kardiol. 1994;83(Suppl 5):101-8 Randomized Controlled Trial
IN StudyID: Zehender 1992 (subordinated publication), atrial fibrillation, persistent The Use of
amiodarone
As Treatment, Acute
Is equal Than
quinidine + verapamil
To acute conversion of chronic AF
J Am Coll Cardiol. 1992 Apr;19(5):1054-9 Randomized Controlled Trial
IN StudyID: Zehender 1992, atrial fibrillation, persistent The Use of
amiodarone
As Treatment, Chronic
Is equal Than
quinidine + verapamil
To acute conversion of chronic AF